Optimal nutritional support plays a pivotal role in the recovery and long-term outcomes of critically ill children. Recent evidence emphasizes the importance of timely, individualized, and mechanism-based nutritional strategies to reduce morbidity, enhance immune function, and support organ recovery in pediatric intensive care units (PICUs). This review synthesizes current data on the epidemiology, pathophysiology, risk factors, clinical features, diagnostic approaches, and evidence-based management of nutrition in critically ill pediatric populations, highlighting advances and consensus guidelines to inform clinical practice.
Critical illness in children is associated with profound metabolic stress and catabolic states, often resulting in significant nutritional deficits that can adversely impact clinical outcomes. Addressing malnutrition and optimizing nutrition delivery in the PICU is paramount for promoting healing, minimizing complications, and supporting growth and development. This article reviews the scientific underpinnings and practical aspects of nutrition-guided recovery for critically ill pediatric patients, providing clinicians with an integrated framework based on recent research and consensus recommendations.
Malnutrition among critically ill children admitted to PICUs is highly prevalent, with studies reporting rates ranging from 20% to 60% depending on the population and assessment methods. The burden of undernutrition or overfeeding is associated with increased morbidity, extended length of stay, higher rates of nosocomial infections, ventilator dependence, and mortality. Epidemiological data indicate that younger age groups, children with underlying chronic diseases, and those requiring prolonged intensive care are particularly susceptible to nutrition-related complications.
The pathophysiology of nutrition deficits in critically ill children is multifactorial and dynamic. Critical illness triggers a hypermetabolic and catabolic response, mediated by inflammatory cytokines, hormonal changes, and increased energy expenditure. There is accelerated protein breakdown, impaired gluconeogenesis, and altered substrate utilization. Moreover, gastrointestinal dysmotility, impaired absorption, and frequent interruptions to enteral feeding due to procedures or hemodynamic instability further exacerbate nutritional deficits. Understanding these mechanisms is essential for developing tailored nutrition interventions that address both macronutrient and micronutrient needs during different phases of critical illness.
Risk factors for poor nutrition status in critically ill children include pre-existing malnutrition, chronic illnesses such as congenital heart disease, cystic fibrosis, or malignancies, and conditions associated with increased metabolic demand. Other contributors are inability to tolerate enteral feeding, gastrointestinal dysfunction, frequent fasting for procedures, and mechanical ventilation. Socioeconomic factors and delayed initiation of nutrition therapy also play significant roles. Early identification of at-risk patients using validated screening tools is vital for prompt intervention.
Clinically, malnutrition in the PICU may manifest as weight loss, muscle wasting, delayed wound healing, increased susceptibility to infections, and impaired recovery from illness. Subtle signs such as growth failure, decreased subcutaneous fat, and edema may also be present. Laboratory findings can include hypoalbuminemia, electrolyte disturbances, and micronutrient deficiencies. Recognizing these features early allows for timely nutritional assessment and intervention, which is crucial for optimizing outcomes.
Assessment of nutritional status in critically ill children should be systematic and ongoing. Key diagnostic tools include anthropometric measurements (weight, height, mid-upper arm circumference), calculation of body mass index (BMI) or weight-for-height z-scores, and assessment of recent weight changes. Biochemical markers such as serum albumin, prealbumin, and transferrin are often affected by acute phase responses and are less reliable for nutritional assessment in acute illness. Functional assessment, dietary history, and validated screening tools such as the Screening Tool for the Assessment of Malnutrition in Paediatrics (STAMP) or STRONGkids are recommended. Indirect calorimetry may be used in selected cases to assess energy expenditure and guide nutrition prescription.
Management of nutrition in critically ill children involves a stepwise approach tailored to individual needs and the phase of illness. Early enteral nutrition (EN) is preferred over parenteral nutrition (PN) whenever feasible, as it preserves gut integrity, reduces infectious complications, and supports immune function. Energy and protein requirements should be estimated based on current guidelines, with careful adjustment for metabolic demands and tolerance. Micronutrient supplementation is critical to correct deficiencies. In cases where EN is not possible or insufficient, PN may be utilized, with vigilant monitoring for complications such as hyperglycemia, electrolyte imbalances, and liver dysfunction. Multidisciplinary collaboration among intensivists, dietitians, pharmacists, and nurses is essential for effective nutrition management.
Recent research has focused on optimizing timing, composition, and route of nutrition delivery in the PICU. Evidence supports the use of individualized energy targets, early permissive underfeeding in select populations, and protein-enriched formulas to preserve lean body mass. Novel approaches include the use of immunonutrition (e.g., glutamine, omega-3 fatty acids), probiotic supplementation, and the integration of continuous versus bolus feeding strategies. Advances in metabolic monitoring, such as indirect calorimetry and body composition analysis, are improving precision in nutrition therapy. Emerging data also suggest that post-PICU nutritional rehabilitation is critical for neurodevelopmental outcomes and quality of life.
Consensus guidelines from organizations such as the Society of Critical Care Medicine (SCCM), American Society for Parenteral and Enteral Nutrition (ASPEN), and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) emphasize early initiation of enteral nutrition, regular assessment of nutrition status, individualized energy and protein targets, and avoidance of overfeeding or underfeeding. Guidelines also advocate for the use of standardized nutrition screening tools, timely micronutrient supplementation, and the minimization of interruptions to feeding. Multidisciplinary nutrition support teams are recommended for complex cases.
Nutrition-guided recovery is a cornerstone of care in critically ill children, with substantial evidence supporting its role in improving clinical outcomes, reducing complications, and enhancing long-term growth and development. Early, individualized, and evidence-based nutrition interventions, guided by current clinical guidelines and ongoing assessment, are essential for optimizing recovery in the PICU. Continued research and innovation in nutrition therapy hold promise for further advances in the care of this vulnerable population.
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa
3.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
4.
A new drug delivery system may help patients with a rare eye cancer
5.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
1.
Clonal Hematopoiesis and Healthy Aging: Clinical Implications, Mechanisms, and Emerging Perspectives
2.
Cemiplimab: A Revolutionary Drug For Treating Cancer
3.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
4.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
5.
Unlocking the Benefits of Eltrombopag: A Comprehensive Guide
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation